May 28, 2020

Webinar: Fully Human Antibody Therapeutics on RenMab Discovery Platform

Register Today
Speaker

Benny Yang, PhD

Chief Scientific Officer & Head of Drug Discovery of Biocytogen

Title

Fully Human Antibody Therapeutics on RenMab Discovery Platform - A Snapshot of Project Integrum

Time
May 28, 2020 1:00 pm
Abstract
1. In vivo antibody discovery using transgenic/humanized mice is of rising importance for the antibody community as it offers a multitude of benefits over in vitro methods. 2. Benefits of in vivo method for antibody discovery and latest technical data including affinity and antibody repertoire analysis for RenMab™ Antibodies. 3. Brief communication of RenMab Mouse in the production of anti-SARS-CoV-2 antibodies as an on-going project. 4. Development of RenMab platform to address difficult target (such as GPCR) through “RenMab + target knockout” (Project Integrum), as well as novel fully human antibody mice for bispecific and single-domain antibodies, respectively